Project Notice
|
| PNR |
1895 |
| Project Name |
UK investment in Gavi, the Vaccine Alliance (2016-2020) - Gavi immunises children against vaccine preventable diseases including measles, rubella, cervical cancer (via the human papilloma virus vaccine) and certain types of pneumonia and diarrhoea. |
| Project Detail |
Gavi currently works in 73 countries to save children’s lives by increasing equitable use of vaccines in the world’s poorest countries (the number will reduce as countries graduate from Gavi support). Gavi immunises children against vaccine preventable diseases including measles, rubella, cervical cancer (via the human papilloma virus vaccine) and certain types of pneumonia and diarrhoea. Pneumonia and diarrhoea are two of the biggest causes of deaths among children in the developing world and cervical cancer is a leading cause of death for women in Africa. Gavi will also have an important role to play if effective vaccines are produced against malaria and ebola. During 2016-2020, Gavi will in particular target reaching those in hard to reach areas in its target countries. Gavi also works with manufacturers to reduce the cost of vaccines for countries. The UK investment through Gavi will immunise an additional 75 million children against diseases and save over 1.25 million lives
Project budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
The current stage of the project, consistent with the International Aid Transparency Initiatives (IATI) classifications.
A project can have up to 8 sectors, which are displayed with percentage allocations that total up to 100%. They are consistent with the Development Assistance Committees (DAC) classifications.
A comparison of forecast spend and the total amount of money spent on the project to date. Some budgets may not be shown if projects are in an active procurement phase. |
| Funded By |
UKAid Department for International Development |
| Sector |
Health & Medical |
| Country |
United States , Northern America |
| Project Value |
USD 1,000,000,000
|
